Back to Results
First PageMeta Content
Rheumatology / Biomarkers / Autoimmune diseases / Rheumatoid arthritis / Anti-citrullinated protein antibody / Personalized medicine / Psoriatic arthritis / Autoimmunity / Medicine / Health / Arthritis


Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker[removed]η as a Testing Service in the U.S. Vancouver, BC – October 9, [removed]Augurex Life Sciences Corp. to
Add to Reading List

Document Date: 2012-11-27 18:33:44

Open Document

File Size: 347,55 KB

Share Result on Facebook

City

Vancouver / /

Company

Quest Diagnostics / Augurex Life Sciences Corp. / CCP / /

Continent

Asia / /

Country

United States / Canada / /

Event

Business Partnership / /

Facility

University of Alberta / American College of Rheumatology / /

MedicalCondition

inflammatory conditions / disease / arthritis / Psoriatic Arthritis / /

Organization

the American College / European League Against Rheumatism / European Union / University of Alberta / Stanford University Medical School / Testing Service / /

Person

Norma Biln / Walter Maksymowych / Mark Genovese / /

Position

principal investigator / Professor of Medicine / Immunology and Rheumatology / Chief Executive Officer / Professor of Medicine / /

ProvinceOrState

Alberta / /

SocialTag